Niki BioSolutions, Inc. (NIKI) · Oct 13, 2026 · Exec change
CFO appointment — $250,000 base salary; $25,000 deferred until $3M funding
Niki BioSolutions appoints Thomas Freeburg as CFO, adding finance experience but tying compensation to future capital raises.
Niki BioSolutions is a recently reorganized, clinical-stage life-sciences company building genomic and biomarker testing capabilities around brain health, oncology, and an Alzheimer’s program after its 2026 merger with DiamiR. The filing completes the post-merger executive buildout with an experienced CFO. Thomas Freeburg brings prior CFO, chief accounting officer, SEC-reporting, and public-company finance experience, and the agreement gives him responsibility for the company’s day-to-day financial operations and financial strategy. 〔0〕 〔1〕 The buried signal is that financing remains central to the operating plan. His $250,000 base salary includes $25,000 deferred until the company receives cumulative capital investment of $3 million, while the salary rises to $275,000 after $5 million of funding. That makes the appointment less a sign of a fully funded platform than a sign the company is still structuring itself around the next raise. 〔2〕 The compensation package is meaningful for an early-stage company but not an obvious strategic reset. Freeburg is eligible for a bonus of up to 50% of base salary and receives 50,000 options at an $8.83 exercise price, adding future dilution potential while aligning part of his compensation with equity value creation. 〔3〕 Bottom line: This is a constructive governance upgrade, but the funding-linked pay terms make the bigger takeaway capital dependence rather than business progress. The direction was already visible from the recent post-merger management buildout, so the filing matters modestly.
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!